📈 Jumpstart Signal Watchlist — September 30, 2026

🏢 What they do: Paysign, Inc. is a payments technology company that provides prepaid card programs, integrated payment processing, and digital banking/payment solutions for businesses, healthcare and pharmaceutical clients, and government or consumer payout programs.
- 🎯 Current $13.48 is 5% below 3yr high $14.14 · ⏳ SMA200 $7.23 (current price $13.48 is above) · 💰 Market Cap $761M
- PAYS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 450% (>20%); Revenue growth 48% (>15%); ROE 26% (>15%); Low LT D/E 0.06 (<1.0).
⏰ Entry (E): 3/20
- 🔔 Strong above EMA21 (5.8%)
- 🔔 Strong above EMA50 (13.4%)
- 📈 RSI at 60 showing strength
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive (✅×1 ⚪️×2).
✅ DA Davidson raises Paysign stock price target to $15 on growth outlook — Investing.com.
🤖 DA Davidson raised its price target to $15 from $12 while maintaining a Buy rating. The higher target and positive growth outlook are favorable signals for PAYS.
⚪️ Paysign EVP, operations Joan Herman sells $716,899 in shares — Investing.com.
🤖 The article reports an insider share sale, a backward-looking transaction rather than a company operating catalyst. It also recaps previously reported quarterly results, which were not published within this article’s reporting period.
⚪️ Paysign chief innovation officer Michael Ngo sells $1.9m in stock — Investing.com.
🤖 The article reports the chief innovation officer’s stock sale, which is a past insider transaction and not by itself a directional catalyst. Its references to second-quarter results are recaps, not new results reported in this article.
🍭 Bonus (B): 0/10 — Business Services

🏢 What they do: Vir Biotechnology is a clinical-stage biopharmaceutical company that develops medicines for serious infectious diseases and cancer. Its work centers on immune-based therapies, including antibody-based and other platform-driven drug candidates such as programs for hepatitis delta, hepatitis B, and solid tumors.
- 🎯 Current $11.18 is 12% below 3yr high $12.66 · ⏳ SMA200 $8.92 (current price $11.18 is above) · 💰 Market Cap $1.9B
- VIR shows decent technicals supported by positive sentiment.

💎 Quality (Q): 32/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 159% (>20%); Low LT D/E 0.00 (<1.0).
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×4; showing 3 of 4).
✅ Vir Biotechnology Stock: Astellas Deal Highlights The Platform's Value — Seeking Alpha.
🤖 The article highlights the Astellas partnership, including $335 million in upfront and near-term payments, as validation of Vir’s PRO-XTEN platform. It also points to the fully enrolled Phase 3 hepatitis delta program and cash runway into the second half of 2028, while noting the market may be undervaluing the pipeline.
✅ Raymond James reiterates Vir Biotechnology stock rating on hepatitis delta data — Investing.com.
🤖 Raymond James maintained its Strong Buy rating and $19 price target after a competitor’s Phase 3 results, saying the data do not change the likelihood of success for Vir’s pivotal studies. The analyst expects Vir’s hepatitis delta treatments to have competitive clinical profiles.
✅ Vir Biotechnology, Inc. (NASDAQ:VIR) Stock Rated "Moderate Buy" by Sell-Side Brokerages — MarketBeat.
🤖 The article reports a Moderate Buy consensus from eight analysts and an average price target of $21.57, above the cited share price. It also notes that Vir’s most recently reported quarterly EPS exceeded consensus, though those results were reported in August.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Bioventus Inc. is a global medical device company that develops and commercializes clinically proven, minimally invasive products to relieve pain and address musculoskeletal challenges by enhancing the body's natural healing process .
- 🎯 Current $13.63 is 11% below 3yr high $15.26 · ⏳ SMA200 $10.18 (current price $13.63 is above) · 💰 Market Cap $921M
- BVS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 39/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 327% (>20%); ROE 24% (>15%); PEG ratio 0.05 (<1.5).
⏰ Entry (E): 2/20
- 📈 RSI at 51 in healthy mid-range
- ⚠️ SMA20/SMA50 bearish crossover
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×3 ⚪️×1; showing 3 of 4).
✅ Bioventus: Cash Flow Anchors The Bull Case Beyond A Potential Sale — Seeking Alpha.
🤖 The article argues that cash flow from established products supports debt reduction and commercial expansion, and notes improved financing terms and reiterated 2026 guidance. It also highlights execution risks around new-product adoption, but its overall investment thesis is bullish.
✅ Bioventus Inc. (NASDAQ:BVS) Stock Now Rated "Moderate Buy" by Wall Street Analysts — MarketBeat.
🤖 The article reports a Moderate Buy consensus, with five Buy ratings and one Hold, and an average price target above the cited share price. It also notes that the latest reported quarter met adjusted EPS estimates and includes 2026 EPS guidance.
⚪️ Bank of New York Mellon Corp Takes Position in Bioventus Inc. — MarketBeat.
🤖 The article reports a new institutional position based on a regulatory disclosure. Under the requested classification, this backward-looking ownership filing is neutral and does not by itself indicate a directional catalyst.
🍭 Bonus (B): 0/10 — Surgical & Medical Instruments

🏢 What they do: Hewlett Packard Enterprise (HPE) is an enterprise technology company that provides compute, storage, networking, and software solutions designed for hybrid IT environments and AI infrastructure.
- 🎯 At/above 3yr high $63.89 (current $63.89) · ⏳ SMA200 $36.25 (current price $63.89 is above) · 💰 Market Cap $84.9B
- HPE shows decent technicals supported by positive sentiment.

💎 Quality (Q): 49/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 405% (>20%); Revenue growth 34% (>15%); Low LT D/E 0.82 (<1.0); PEG ratio 0.08 (<1.5).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.4%)
- 🔔 Strong above EMA50 (15.7%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 62 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ HPE Secures Its First AMD Helios Order in $1.2 Billion Deal With Vultr — Business Wire.
🤖 Vultr placed a $1.2 billion order for HPE’s AMD Helios AI systems, marking the first order for the new system. The large AI infrastructure deal signals meaningful customer demand for HPE’s products.
✅ HPE to Outline Networking Priorities for Long-term Value Creation — Business Wire.
🤖 HPE raised its projected Networking revenue growth to a high-teens CAGR from FY26 through FY29. The higher long-term outlook points to stronger expected growth in a key business segment.
✅ HPE's Networking Orders Signal Continued Growth — Zacks.
🤖 The article highlights 36% year-over-year growth in normalized networking orders and $700 million in AI networking orders during the quarter. Strong orders and demand support the outlook for continued networking growth, though supply constraints remain a consideration.
🍭 Bonus (B): 10/10 — Computer & Office Equipment (Technology sector)

🏢 What they do: Magnite is an advertising technology company that provides a sell-side platform for digital advertising. Its software helps publishers and media owners manage and monetize ad inventory across channels like connected TV, video, mobile, and desktop, while also connecting them with advertisers and agencies.
- 🎯 Current $25.26 is 5% below 3yr high $26.52 · ⏳ SMA200 $16.81 (current price $25.26 is above) · 💰 Market Cap $3.6B
- MGNI shows decent technicals supported by positive sentiment.

💎 Quality (Q): 50/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 62% (>20%); ROE 18% (>15%); Low LT D/E 0.37 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (10.1%)
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ MGNI Stock Heads For Another Month In Green: Magnite ... — Yahoo Finance.
🤖 BofA raised its price target on Magnite to $38 from $25 while maintaining a Buy rating, citing a more favorable growth outlook. The higher target and continued Buy rating are positive analyst signals.
✅ Magnite's Growth Outlook Improves 'Considerably' After Google Court Ruling, BofA Says — Yahoo Finance.
🤖 BofA said Magnite’s growth outlook improved considerably following the Google court ruling, which could benefit the company’s advertising business. The article reports a favorable analyst view of the potential opportunity.
⚪️ Magnite Promotes Brian Gephart to Chief Financial Officer — GlobeNewswire.
🤖 Magnite promoted Brian Gephart, its Chief Accounting Officer since 2021, to CFO effective October 1, succeeding David Day. The announcement describes a leadership transition but provides no specific financial outlook or operating impact.
🍭 Bonus (B): 10/10 — Computer Programming & Data Processing (Technology sector)

🏢 What they do: Worthington Enterprises designs and manufactures building and consumer products, including HVAC and water systems, metal roofing and ceiling components, tools, portable propane and helium cylinders, outdoor-living products, and celebration supplies. Its brands include Bernzomatic, Balloon Time, Coleman propane cylinders, Garden Weasel, and LEVEL5 Tools.
- 🎯 Current $59.54 is 12% below 3yr high $67.39 · ⏳ SMA200 $55.37 (current price $59.54 is above) · 💰 Market Cap $2.9B
- WOR shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (14.2% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 978% (>20%); ROE 15% (>15%); Low LT D/E 0.30 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 52 in healthy mid-range
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ Worthington Enterprises Shares Jump 15% on Strong ... — Yahoo Finance.
🤖 Shares rose after fiscal Q1 revenue increased 13%, adjusted EBITDA grew 10%, and free cash flow nearly doubled. The company also cited growing demand for tanks used in data-center liquid cooling and continued shareholder returns.
✅ Worthington Enterprises Q1 Earnings Call Highlights — Yahoo Finance.
🤖 Fiscal Q1 sales rose 13%, adjusted EPS increased to $0.82 from $0.78, and adjusted EBITDA grew 10%. The results indicate year-over-year growth across key financial measures.
⚪️ Worthington Enterprises Announces Investor Day; Renames Business Segments — Yahoo Finance.
🤖 The company announced an upcoming investor day and renamed its business segments to better describe their markets. The article says the changes are names only and do not alter segment composition or historical results, so it reports no clear financial catalyst.
🍭 Bonus (B): 0/10 — Steel Works & Blast Furnaces

🏢 What they do: ScanSource is a technology distributor that connects hardware, software, connectivity, and cloud solutions to channel partners and businesses. Its products and services include point-of-sale systems, barcode and data-capture equipment, networking, communications, physical security, payments, and related value-added services.
- 🎯 Current $58.73 is 0% below 3yr high $58.89 · ⏳ SMA200 $45.54 (current price $58.73 is above) · 💰 Market Cap $1.2B
- SCSC shows decent technicals supported by positive sentiment.

💎 Quality (Q): 54/60
- 🏦 Low drawdown (12.7% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 40% (>20%); Revenue growth 17% (>15%); Low LT D/E 0.38 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ ScanSource (SCSC) Shows Fast-paced Momentum But Is Still a Bargain Stock — Yahoo Finance.
🤖 The article cites upward earnings-estimate revisions and a Zacks Rank of Strong Buy, alongside favorable momentum. These factors suggest a positive analyst outlook for SCSC.
✅ ScanSource (SCSC) Stock May Still Trade Below Fair Value As Shares Rose 90% — Yahoo Finance.
🤖 The article argues that ScanSource may remain below fair value despite its substantial share-price gains over three years. That valuation view could support further upside, while the past gains are also noted.
✅ ScanSource (SCSC) Momentum Run Keeps Fair Value In Focus — Yahoo Finance.
🤖 The article highlights recent share-price momentum and a fair-value estimate above the current price. Its valuation and performance discussion presents a favorable view of SCSC.
🍭 Bonus (B): 0/10 — Computers & Software - Wholesale

🏢 What they do: Karat Packaging Inc. manufactures and distributes disposable foodservice products used by restaurants and other foodservice businesses. Its products include food and take-out containers, cups, lids, cutlery, straws, tableware, bags, and compostable packaging, along with related supplies and services.
- 🎯 Current $52.55 is 3% below 3yr high $54.16 · ⏳ SMA200 $32.22 (current price $52.55 is above) · 💰 Market Cap $1.0B
- KRT shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (13.7% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 170% (>20%); ROE 30% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (12.5%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 66 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (mixed coverage; ✅×4 ❌×1; showing 3 of 5).
✅ Zacks Industry Outlook Highlights Avery Dennison, AptarGroup and Karat Packaging — Zacks.
🤖 The article notes Karat Packaging's record second-quarter sales, supported by customer demand and online-business momentum, and rising earnings estimates. These factors suggest improving business performance and expectations.
✅ 3 Packaging Stocks Worth Watching Despite Industry Challenges — Yahoo Finance.
🤖 The article highlights a 69% expected year-over-year increase in KRT's 2026 earnings estimate and a substantial recent upward revision. It also reports a Zacks Rank of 3, indicating a more mixed overall assessment.
❌ Karat Packaging: After A 100% Rally, Expectations Look Much Higher (Rating Downgrade) — Seeking Alpha.
🤖 The article downgrades KRT from Buy to Hold, citing elevated valuation after a sharp rally and concerns that second-quarter earnings benefited from a one-time tariff refund. It also flags that the dividend payout exceeds normalized free cash flow.
🍭 Bonus (B): 0/10 — Rubber & Plastics Products